Prognostic impact of comorbidity among long-term breast cancer survivors: Results from the LACE study

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 7, 2012, Pages 1115-1125

  Braithwaite, Dejana ^a   Moore, Dan H ^a   Satariano, William A ^b   Kwan, Marilyn L ^c   Hiatt, Robert A ^a   Kroenke, Candyce ^c   Caan, Bette J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGED; ARTHRITIS; ARTICLE; ASTHMA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CIGARETTE SMOKING; COMORBIDITY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; LIFESTYLE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MASTECTOMY; NEPHROLITHIASIS; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOCIAL STATUS; STROKE; ULCER;

ADULT; AGED; BREAST NEOPLASMS; CALIFORNIA; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; SURVIVORS; YOUNG ADULT;

EID: 84863574647     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-1228     Document Type: Article

References (45)

1. American Cancer Society. Cancer facts and figures; 2011.
2. Bigby J, Holmes MD. Disparities across the breast cancer continuum. Cancer Causes Control 2005;16:35-44. (Pubitemid 40568849)
3. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 2005;294:1765-72. (Pubitemid 41434622)
4. West DW, Satariano WA, Ragland DR, Hiatt RA. Comorbidity and breast cancer survival: a comparison between black and whitewomen. Ann Epidemiol 1996;6:413-9. (Pubitemid 26372529)
5. Hershman D, McBride R, Jacobson JS, Lamerato L, Roberts K, Grann VR, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 2005;23:6639-46. (Pubitemid 46190258)
6. Tammemagi CM. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opin Obstet Gynecol 2007; 19:31-6. (Pubitemid 46095870)
7. Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer 1997;80:1273-83. (Pubitemid 27407230)
8. Yancik R, Havlik RJ, Wesley MN, Ries L, Long S, Rossi WK, et al. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol 1996;6:399-412. (Pubitemid 26372528)
9. Yancik R. Epidemiology of cancer in the elderly. Current status and projections for the future. Rays 1997;22(1 Suppl):3-9. (Pubitemid 27288048)
10. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994;120:104-10. (Pubitemid 24027550)
11. Stricker CT, Jacobs LA, Risendal B, Jones A, Panzer S, Ganz PA, et al. Survivorship care planning after the Institute of Medicine recommendations: how are we faring? J Cancer Surviv 2011;5: 358-70.
12. Caan B, Sternfeld B, Gunderson E, Coates A, Quesenberry C, Slattery ML. Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control 2005;16:545-56. (Pubitemid 40933624)
13. Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER, Flatt SW, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 2007;298: 289-98. (Pubitemid 47080483)
14. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care 1996;34:73-84. (Pubitemid 126433198)
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. (Pubitemid 17055592)
16. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-51. (Pubitemid 24361532)
17. Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, et al. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer 2009;124:1213-9.
18. Emaus A, Veierod MB, Tretli S, Finstad SE, Selmer R, Furberg AS, et al. Metabolic profile, physical activity, and mortality in breast cancer patients. Breast Cancer Res Treat 2010;121:651-60.
19. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998;158:1855-67.
20. Staten LK, Taren DL, Howell WH, Tobar M, Poehlman ET, Hill A, et al. Validation of the Arizona activity frequency questionnaire using doubly labeled water. Med Sci Sports Exerc 2001;33:1959-67. (Pubitemid 33035495)
21. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32(9 Suppl): S498-504.
22. Fleming ID, Cooper JS, Henson DE. AJCC Cancer staging manual. 5th ed. New York, NY: Lippincott-Raven 1997.
23. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79:340-9. (Pubitemid 19077878)
24. Cox DR, Oakes D. Analysis of survival data. Monographs in statistics and applied probability 21. New York, NY: Chapman & Hill; 1994.
25. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. Statistics for Biology and Health. New York: Springer- Verlag; 2000.
26. Prentice RL, Kalbfleisch JD. Hazard rate models with covariates. Biometrics 1979;35:25-39. (Pubitemid 9136564)
27. Nagel G, Wedding U, Hoyer H, Rohrig B, Katenkamp D. The impact of comorbidity on the survival of postmenopausal women with breast cancer. J Cancer Res Clin Oncol 2004;130:664-70. (Pubitemid 39506380)
28. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 2008;300:2754-64.
29. Patterson RE, Flatt SW, Saquib N, Rock CL, Caan BJ, Parker BA, et al. Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat 2010;122:859-65.
30. Patnaik JL, Byers T, Diguiseppi C, Denberg TD, Dabelea D. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 2011;103: 1101-11.
31. Land LH, Dalton SO, Jensen MB, Ewertz M. Impact of comorbidity on mortality: a cohort study of 62,591 Danishwomen diagnosed with early breast cancer, 1990-2008. Breast Cancer Res Treat 2012;131: 1013-20.
32. Dyer AR, Stamler J, Berkson DM, Lindberg HA, Stevens E. High blood-pressure: a risk factor for cancer mortality? Lancet 1975;1: 1051-6.
33. Jung SY, Rosenzweig M, Linkov F, Brufsky A, Weissfeld JL, Sereika SM. Comorbidity as a mediator of survival disparity between younger and older women diagnosed with metastatic breast cancer. Hypertension 2012;59:205-11.
34. Meyer P. Increased intracellular calcium: from hypertension to cancer. J Hypertens Suppl 1987;5:S3-4. (Pubitemid 18035031)
35. Norden A, Schersten B, Thulin T, Pero RW, Bryngelsson C, Mitelman F. Letter: hypertension related to DNA repair synthesis and carcinogen uptake. Lancet 1975;2:1094.
36. Hamet P. Cancer and hypertension. An unresolved issue. Hypertension 1996;28:321-4.
37. Extermann M. Interaction between comorbidity and cancer. Cancer Control 2007;14:13-22. (Pubitemid 46168962)
38. Read WL, Tierney RM, Page NC, Costas I, Govindan R, Spitznagel EL, et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004;22:3099-103. (Pubitemid 41103722)
39. Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowske K, et al. Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst 2010;102:1468-77.
40. Greenfield S, Blanco DM, Elashoff RM, Ganz PA. Patterns of care related to age of breast cancer patients. JAMA 1987;257: 2766-70. (Pubitemid 17066520)
41. Newschaffer CJ, Bush TL, Penberthy LT. Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data. J Clin Epidemiol 1997;50:725-33. (Pubitemid 27341823)
42. Frasci G, Lorusso V, Panza N, Comella P, Nicolella G, Bianco A, et al. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 2000;18:2529-36. (Pubitemid 30432518)
43. Satariano WA, Ragland DR. Upper-body strength and breast cancer: a comparison of the effects of age and disease. J Gerontol A Biol Sci Med Sci 1996;51:M215-9.
44. Satariano WA, Ragland DR, DeLorenze GN. Limitations in upper-body strength associated with breast cancer: a comparison of black and white women. J Clin Epidemiol 1996;49: 535-44. (Pubitemid 26195609)
45. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 2006;56:168-83. (Pubitemid 43847927)